To characterize the incidence risk of serious infections and malignancies among adult myasthenia gravis (MG) patients compared to matched controls in the general population.
No takes yet. Share an insight, caveat, or question.
Podhorna et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: